Share URL
Embed chart view
StockViz
Glaukos Corporation
NYSE:GKOS
Sector
Location
Market Cap
USD 5.37 B
Share Price
USD 94.05
Avg Daily Volume
959,166
Change (1 day)
0.31%
Change (1 year)
-20.22%
Change (YTD)
-37.28%
Glaukos Corporation Enterprise Value to EBITDA (EV/EBITDA) on July 30, 2025: -64.97
Glaukos Corporation Enterprise Value to EBITDA (EV/EBITDA) is -64.97 on July 30, 2025, a 5.76% change year over year. EV/EBITDA ratio compares the enterprise value to the EBITDA; lower suggests more favorable company valuation.
-
Glaukos Corporation 52-week low Enterprise Value to EBITDA (EV/EBITDA) is -55.50 on July 30, 2025, which is 14.57% above the current Enterprise Value to EBITDA (EV/EBITDA).
-
Glaukos Corporation 52-week low Enterprise Value to EBITDA (EV/EBITDA) is -100.71 on July 30, 2025, which is -55.00% below the current Enterprise Value to EBITDA (EV/EBITDA).
-
Glaukos Corporation average Enterprise Value to EBITDA (EV/EBITDA) for the last 52 weeks is -73.57.
Competitors
Santen Pharmaceutical Co., Ltd.
USD 11.25
4536.T
+0.13
1.15%
Shenyang Xingqi Pharmaceutical Co.,Ltd
USD 9.13
300573.SZ
+0.22
2.42%
Ocular Therapeutix, Inc.
USD 11.66
OCUL
-0.09
-0.77%
Eli Lilly and Company
USD 760.08
LLY
-2.87
-0.38%
AbbVie Inc.
USD 189.31
ABBV
-1.91
-1.00%
Roche Holding AG
USD 337.03
RO.SW
-3.75
-1.10%
AstraZeneca PLC
USD 152.16
AZN.L
+3.29
2.21%
Merck & Co., Inc.
USD 81.75
MRK
-0.88
-1.06%
Amgen Inc.
USD 301.37
AMGN
-2.19
-0.72%
Gilead Sciences, Inc.
USD 114.76
GILD
+0.53
0.46%
Pfizer Inc.
USD 23.81
PFE
-0.49
-2.02%
Sanofi
USD 97.52
SAN.PA
-1.60
-1.62%
Bristol-Myers Squibb Company
USD 45.98
BMY
-0.88
-1.88%
Chugai Pharmaceutical Co., Ltd.
USD 49.79
4519.T
+0.26
0.52%
GSK plc
USD 19.35
GSK.L
+0.72
3.84%
Key Data
| Date | Enterprise Value to EBITDA (EV/EBITDA) | Free Cash Flow Yield | Dividend Yield | Market Capitalization |
|---|
Competitors
Santen Pharmaceutical Co., Ltd.
USD 11.25
4536.T
+0.13
1.15%
Shenyang Xingqi Pharmaceutical Co.,Ltd
USD 9.13
300573.SZ
+0.22
2.42%
Ocular Therapeutix, Inc.
USD 11.66
OCUL
-0.09
-0.77%
Eli Lilly and Company
USD 760.08
LLY
-2.87
-0.38%
AbbVie Inc.
USD 189.31
ABBV
-1.91
-1.00%
Roche Holding AG
USD 337.03
RO.SW
-3.75
-1.10%
AstraZeneca PLC
USD 152.16
AZN.L
+3.29
2.21%
Merck & Co., Inc.
USD 81.75
MRK
-0.88
-1.06%
Amgen Inc.
USD 301.37
AMGN
-2.19
-0.72%
Gilead Sciences, Inc.
USD 114.76
GILD
+0.53
0.46%
Pfizer Inc.
USD 23.81
PFE
-0.49
-2.02%
Sanofi
USD 97.52
SAN.PA
-1.60
-1.62%
Bristol-Myers Squibb Company
USD 45.98
BMY
-0.88
-1.88%
Chugai Pharmaceutical Co., Ltd.
USD 49.79
4519.T
+0.26
0.52%
GSK plc
USD 19.35
GSK.L
+0.72
3.84%